Urine cfDNA Test for HCC Monitoring

About JBS Science

JBS Science is a privately-held diagnostics company founded in 2008 and incorporated in 2011, headquartered in San Diego, CA. It has developed proprietary technologies for cfDNA isolation and sensitive qPCR assays, aiming to detect primary and recurrent cancers via a simple urine test. The company has been primarily funded through multiple NIH SBIR grants, including a significant $3 million Bridge Award from the NCI, and has established key collaborations and a licensing agreement for its isolation kits. Its current focus appears to be on liver cancer (HCC) screening, with data presented at major hepatology and oncology conferences.

Therapeutic Areas